jt, from your link...
"Even his medical team was taken aback. Dr Dickinson said: “It’s a drug that may not always be especially active by itself in this subtype of lymphoma, but it has definitely had a miraculous response in Jessy"
Tacti-mel by prima is a trial re melanoma in patients where keytruda alone didn't do them any good.
IMP321 is being used in combo with keytruda in those patients that didn't respond to keytruda....If this
combo works it will be good for all concerned..
Ann: PRR completes recruitment for 2nd patient cohort, page-7
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.5¢ | 32.0¢ | $1.303M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29843 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 105523 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |